Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome
暂无分享,去创建一个
Z. Szentirmay | E. Oláh | J. Papp | M. Kovacs | S. Ottó
[1] M. Harmsen,et al. Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule. , 2007, The American journal of pathology.
[2] E. Oláh,et al. Germline MLH1 and MSH2 mutational spectrum including frequent large genomic aberrations in Hungarian hereditary non-polyposis colorectal cancer families: implications for genetic testing. , 2007, World journal of gastroenterology.
[3] K. Kinzler,et al. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. , 2007, Journal of the National Cancer Institute.
[4] S. Chattopadhyay,et al. MARs and MARBPs , 2007, Chromatin and Disease.
[5] M. Kloor,et al. Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] S. Leung,et al. Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer , 2006, Nature Genetics.
[7] Z. Szentirmay,et al. Pedigree and genetic analysis of a novel mutation carrier patient suffering from hereditary nonpolyposis colorectal cancer. , 2006, World journal of gastroenterology.
[8] P. Møller,et al. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC) , 2005, Genes, chromosomes & cancer.
[9] S. Thibodeau,et al. Characterization of hMLH1 and hMSH2 gene dosage alterations in Lynch syndrome patients. , 2005, Gastroenterology.
[10] A. Lindblom,et al. The 5′ region of the MSH2 gene involved in hereditary non‐polyposis colorectal cancer contains a high density of recombinogenic sequences , 2005, Human mutation.
[11] Thomas Werner,et al. MatInspector and beyond: promoter analysis based on transcription factor binding sites , 2005, Bioinform..
[12] K. Shearwin,et al. Transcriptional interference--a crash course. , 2005, Trends in genetics : TIG.
[13] H. Lynch,et al. Hereditary colorectal cancer-part II. , 2005, Current problems in surgery.
[14] D. Kleinjan,et al. Long-range control of gene expression: emerging mechanisms and disruption in disease. , 2005, American journal of human genetics.
[15] L. Maquat. Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics , 2004, Nature Reviews Molecular Cell Biology.
[16] A. Lindblom,et al. Screening for genomic rearrangements of the MMR genes must be included in the routine diagnosis of HNPCC , 2004, Journal of Medical Genetics.
[17] David I. K. Martin,et al. Germline epimutation of MLH1 in individuals with multiple cancers , 2004, Nature Genetics.
[18] A. de la Chapelle,et al. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. , 2003, American journal of human genetics.
[19] D. Zwijnenburg,et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. , 2002, Nucleic acids research.
[20] T. Werner,et al. In silico prediction of scaffold/matrix attachment regions in large genomic sequences. , 2002, Genome research.
[21] S. Antonarakis,et al. Nomenclature for the description of human sequence variations , 2001, Human Genetics.
[22] M. King,et al. Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary , 2000, International journal of cancer.
[23] S. Antonarakis,et al. Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion , 2000 .
[24] S Srivastava,et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.
[25] K. Maruyama,et al. Promoter analysis of the human mismatch repair gene hMSH2. , 1998, Gene.
[26] B. Ponder,et al. Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer. , 1997, American journal of human genetics.
[27] B. Ponder,et al. A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2 , 1997, Nature Genetics.
[28] Marvin B. Shapiro,et al. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. , 1987, Nucleic acids research.
[29] N. Proudfoot,et al. Alpha‐thalassaemia caused by a poly(A) site mutation reveals that transcriptional termination is linked to 3′ end processing in the human alpha 2 globin gene. , 1986, The EMBO journal.
[30] S. Goodbourn,et al. α-Thalassaemia caused by a polyadenylation signal mutation , 1983, Nature.